DK1158962T3 - Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer - Google Patents

Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer

Info

Publication number
DK1158962T3
DK1158962T3 DK00916925T DK00916925T DK1158962T3 DK 1158962 T3 DK1158962 T3 DK 1158962T3 DK 00916925 T DK00916925 T DK 00916925T DK 00916925 T DK00916925 T DK 00916925T DK 1158962 T3 DK1158962 T3 DK 1158962T3
Authority
DK
Denmark
Prior art keywords
dosage forms
preparing solid
containing dosage
solid cyclodextrin
cyclodextrin
Prior art date
Application number
DK00916925T
Other languages
English (en)
Inventor
Gunther Berndl
Stephan Lehmann
Ulrich Reinhold
Dirk Simon
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK1158962T3 publication Critical patent/DK1158962T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00916925T 1999-03-12 2000-03-10 Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer DK1158962T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19911097A DE19911097A1 (de) 1999-03-12 1999-03-12 Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen
PCT/EP2000/002142 WO2000054751A1 (de) 1999-03-12 2000-03-10 Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen

Publications (1)

Publication Number Publication Date
DK1158962T3 true DK1158962T3 (da) 2003-01-06

Family

ID=7900771

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00916925T DK1158962T3 (da) 1999-03-12 2000-03-10 Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer

Country Status (10)

Country Link
EP (1) EP1158962B1 (da)
JP (1) JP4861552B2 (da)
AT (1) ATE228828T1 (da)
BR (1) BR0008872B1 (da)
CA (1) CA2367020C (da)
DE (2) DE19911097A1 (da)
DK (1) DK1158962T3 (da)
ES (1) ES2187457T3 (da)
PT (1) PT1158962E (da)
WO (1) WO2000054751A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
EP1278549B1 (en) 2000-05-02 2008-12-10 Theravance, Inc. Composition containing a cyclodextrin and a glycopeptide antibiotic
WO2001083520A2 (en) 2000-05-02 2001-11-08 Theravance,Inc Polyacid glycopeptide derivatives
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
AU2001259816A1 (en) 2000-06-22 2002-01-02 Advanced Medecine, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
WO2001098327A2 (en) 2000-06-22 2001-12-27 Theravance, Inc. Glycopeptide carboxy-saccharide derivatives
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
DE10141682A1 (de) * 2001-08-25 2003-03-06 Beiersdorf Ag Verwendung von Cyclodextrinen zur Herstellung kosmetischer und dermatologischer Zubereitungen mit verbesserter Verteilbarkeit von Füllstoffen auf der Haut sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an Cyclodextrinen und Füllstoffen
DE10157350A1 (de) * 2001-11-22 2003-05-28 Stockhausen Chem Fab Gmbh Herstellung von Wirkstoffzusammensetzung durch Extrudieren von wasserabsorbierenden Polymeren
US7001893B2 (en) * 2002-10-28 2006-02-21 Council Of Scientific And Industrial Research Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US7955630B2 (en) * 2004-09-30 2011-06-07 Kraft Foods Global Brands Llc Thermally stable, high tensile strength encapsulated actives
ES2310948B2 (es) 2005-02-25 2009-09-16 Universidade De Santiago De Compostela Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
EP3337459A1 (de) * 2015-08-21 2018-06-27 Basf Se Salze von wirkstoffen mit polymeren gegenionen
CN107920998B (zh) * 2015-08-21 2021-07-27 巴斯夫欧洲公司 基于n-乙烯基吡咯烷酮和丙烯酸的水溶性聚合物作为药物助剂的用途
KR20190005823A (ko) * 2016-02-04 2019-01-16 잡 리써치 앤드 디벨롭먼트, 엘엘씨 제어된-방출 및 혼층 사이클로덱스트린 내포 복합체 비히클
DE102016014603A1 (de) 2016-06-30 2018-01-04 Thomas Herkenroth Synthetisches Ayahuasca
PH12021552553A1 (en) * 2019-04-16 2022-06-20 Celagenex Res India Pvt Ltd Synergistic lipid controlling compositions
CN113081989B (zh) * 2021-03-29 2022-10-21 海南普利制药股份有限公司 别嘌醇缓释片剂
CN113861347A (zh) * 2021-11-02 2021-12-31 南京信息工程大学 改性环糊精高分子缓释薄荷香型材料及制备方法和应用
CN114588123B (zh) * 2022-04-13 2023-12-22 苏州中化药品工业有限公司 一种高稳定性盐酸西替利嗪片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0624903A (ja) * 1992-04-09 1994-02-01 Nippon Bayeragrochem Kk 植物処理剤
DE4446470A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von teilbaren Tabletten
HUP9900730A3 (en) * 1995-11-23 2001-04-28 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion

Also Published As

Publication number Publication date
DE19911097A1 (de) 2000-09-14
PT1158962E (pt) 2003-04-30
EP1158962B1 (de) 2002-12-04
BR0008872A (pt) 2002-01-02
CA2367020A1 (en) 2000-09-21
DE50000866D1 (de) 2003-01-16
JP4861552B2 (ja) 2012-01-25
WO2000054751A1 (de) 2000-09-21
ES2187457T3 (es) 2003-06-16
BR0008872B1 (pt) 2011-05-17
CA2367020C (en) 2008-12-16
JP2002539151A (ja) 2002-11-19
ATE228828T1 (de) 2002-12-15
EP1158962A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
DE50000866D1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
DE60214012D1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
MXPA05008938A (es) Quetoaldehidos macromoleculares.
DK2347770T4 (da) Fremgangsmåde til fremstilling af en injicerbar farmaceutisk tilberedning
WO2002101412A3 (en) Spray freeze-dried compositions
WO2003077882A3 (en) Preparation of sterile stabilized nanodispersions
EP1646366A4 (en) METHOD FOR PRODUCING MIXED FORMULATION FROM MICRO BEARINGS WITH DELAYED RELEASE THROUGH A CONTINUOUS UNIVERSAL PROCESS
NO20012548D0 (no) Forbedrede ukomplekserte cyklodekstrinsammensetninger for luktkontroll
ATE407664T1 (de) Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.
ATE310506T1 (de) Biodegradierbare polyphosphoester- zusammensetzungen zur behandlung von ovarialkrebs
AU2001266033A1 (en) Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE315596T1 (de) Verfahren zur herstellung kautschukhaltiger thermoplastischer formmassen
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
DE60225262D1 (de) Granulatförmige zusammensetzungen und verfahren zu ihrer herstellung
BR0010292A (pt) Métodos para a preparação de bateladas pré-reagidas de matérias primas para a produção de fórmulas de vidro
DE69923426D1 (de) Verfahren zur herstellung von isoflavonen
ATE346589T1 (de) Herstellung eines direkt verpressbaren tablettierhilfsstoffes
AU4621500A (en) Novel aluminosiloxane compound and process for preparing the same
YU72802A (sh) Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE60129929D1 (de) Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten
EP1342706A4 (en) PROCESS FOR PREPARING A MOLECULAR COMPOUND
ATE259784T1 (de) Propanolaminotetraline, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen